ÂÜÀòÂÒÂ×

Hans Fliri is the current Chairman at Selcia. Hans has over 25 years of experience in the pharmaceutical industry. Prior to joining Selcia, they were the VP of Drug Discovery at Cetek Corporation from January 2000 to December 2002. From October 1994 to September 2000, they were the Senior Director at Rhone Poulenc-Rorer.

Hans Fliri completed their Ph.D. in Chemistry at Leopold-Franzens Universität Innsbruck.

Chris Winfield - Director, Radiochemistry & Analytics, Clive Cornell - Chief Operating Officer, and Carol Austin - Senior Management report to Hans Fliri.